Comparing anti-drug antibody signal-to-noise ratios to assess immunogenicity and interchangeability in adalimumab biosimilar studies.

Background: To support an interchangeability designation for Sandoz adalimumab biosimilar (GP2017), antidrug antibody (ADA) signal-to-noise (S/N) ratios were assessed in the GP2017 ADACCESS trial to directly assess potential changes in immunogenicity.

Research Design And Methods: ADACCESS was a 51-week trial in patients with moderate-to-severe plaque psoriasis that included patients treated continuously with reference adalimumab (cH), and patients who experienced four switches between reference adalimumab and GP2017 (H2H). ADAs were measured every 6 weeks during the switching phase using an electrochemiluminescence assay.

The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.

Pharmacogenetics promises to optimize treatment-related outcomes by informing optimal drug selection and dosing based on an individual's genotype in conjunction with other important clinical factors. Despite significant evidence of genetic associations with drug response, pharmacogenetic testing has not been widely implemented into clinical practice. Among the barriers to broad implementation are limited guidance for how to successfully integrate testing into clinical workflows and limited data on outcomes with pharmacogenetic implementation in clinical practice.

Methodology and data for quantifying storm erosion potential considering sea level rise.

This dataset quantifies storm intensity of approximately 130 unique historical storms along the New Jersey coastline from 1980 to 2014 for three separate sea level conditions. Namely, (1) as observed in the historical record; (2) detrended to 1997 mean sea level and (3) adjusted to the 2050 and 2100 sea level rise scenarios presented in the International Panel on Climate Change's (IPCC) Sixth Assessment Report (AR6). Projected sea level scenarios are adjusted to include local vertical land movement.

In vivo biocompatibility of a new hydrophobic coated Al/AlO nanowire surface on stents.

Background: Intima proliferation and in-stent restenosis is a challenging situation in interventional treatment of small vessel obstruction. Al/AlO nanowires have been shown to accelerate vascular endothelial cell proliferation and migration in vitro, while suppressing vascular smooth muscle cell growth. Moreover, surface modification of Al/AlO nanowires with poly[bis(2,2,2-trifluoromethoxy)phosphazene (PTFEP) coating enables further advantages such as reduced platelet adhesion.

Per- and polyfluoroalkyl substances (PFAS) fate and transport across a groundwater-surface water interface.

Per- and polyfluoroalkyl substances (PFAS) are emerging contaminants of concern whose fate and transport in environmental media are incompletely understood. In the 1960s, PFAS were dumped in the House Street Disposal Site, an unlined landfill on the crest of a glacial end moraine near Rockford, Michigan, USA. In 2017, PFAS were discovered in groundwater and subsequently, a network of monitoring wells delineated a 2 mi (3 km) PFAS plume migrating downgradient toward the Rogue River.